Bicycle Therapeutics Email Format

Biotechnology Research
201-500 employees
Cambridge, England, UK

Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing bicyclic peptide-based medicines to treat cancer and other diseases with operations in the UK and US.

Find contacts at Bicycle Therapeutics

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

first.last@bicycletx.com

Company Overview

Industry
Biotechnology Research
Founded
2009
Headquarters
Cambridge, England, UK
Revenue
$25M-$50M
FUNDING Stage
Public
Key Executives
Kevin Lee (Chief Executive Officer), Travis Thompson (Chief Financial Officer), Jennifer Perry, Pharm.D. (Chief Operating Officer)

Tech Stack

Databricks

Analytics

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Bicycle Therapeutics?

Bicycle Therapeutics uses the first.last format, so Jane Smith would be jane.smith@bicycletx.com.

What technology platform is Bicycle Therapeutics building its oncology pipeline on?

Bicycle Therapeutics is built around bicyclic peptides, fully synthetic short peptides constrained into two loops that are designed to penetrate solid tumors with high affinity and selectivity. Every candidate in the pipeline, from Bicycle Drug Conjugates to Bicycle Radioconjugates, is derived from this platform.

Who founded Bicycle Therapeutics and when was the company established?

Bicycle Therapeutics was founded in 2009 by Sir Greg Winter, who later won the Nobel Prize in Chemistry in 2018 for his pioneering work in phage display. Professor Christian Heinis also contributed foundational work to the Bicycle technology platform.

What is the lead clinical program at Bicycle Therapeutics as of 2026?

Nuzefatide pevedotin, a Bicycle Drug Conjugate targeting EphA2, is the lead program at Bicycle Therapeutics in 2026. A Phase 2 trial in recurrent metastatic pancreatic ductal adenocarcinoma began enrolling patients in March 2026, with the first patient dosed in April 2026.

How can I find and verify the right contact at Bicycle Therapeutics for outreach?

Bicycle Therapeutics operates across its Cambridge, UK headquarters at Granta Park and a US office in Lexington, Massachusetts. Tools like Clay can help you verify a specific contact's email using the first.last@bicycletx.com format before reaching out.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles